However, only about 50% of the TB patients affected by the bacteria susceptible to be killed with the first line anti-TB drugs and a fraction of the MDR TB, which is much more expensive and difficult to treat disease, avail the free TB services …
Hebei Xingang Pharmaceutical Co., Ltd.
Professional manufacturer of Rifampicin and Rifamycin Derivatives
However, only about 50% of the TB patients affected by the bacteria susceptible to be killed with the first line anti-TB drugs and a fraction of the MDR TB, which is much more expensive and difficult to treat disease, avail the free TB services …